BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3917369)

  • 1. Immunogenicity and immunosensitivity of a guinea pig B-cell leukemia subline lacking cell surface Ia antigens.
    Tanio Y; Zbar B
    Cancer Res; 1985 Jan; 45(1):143-8. PubMed ID: 3917369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization.
    Burger R; Clement L; Schroer J; Chiba J; Shevach EM
    J Immunol; 1981 Jan; 126(1):32-7. PubMed ID: 6935294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-activated guinea-pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies.
    Burger R; Scher I; Sharrow SO; Shevach EM
    Immunology; 1984 Jan; 51(1):93-102. PubMed ID: 6197362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules.
    Konen TG; Green I; Shevach EM; Kask AM; Schwartz BD
    J Immunol; 1976 Nov; 117(5 Pt.2):1966-70. PubMed ID: 62799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens.
    Forni G; Shevach EM; Green I
    J Exp Med; 1976 May; 143(5):1067-81. PubMed ID: 1262783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies of the guinea pig L2C leukemia.
    Green I; Forni G; Konen T; Hu CP; Schwartz BD; Kask A; Shevach EM
    Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a model of chronic lymphocytic leukemia in inbred strain 2 guinea pigs.
    Key ME; Brandhorst JS; Bucana CD; Hanna MG
    J Natl Cancer Inst; 1983 Jun; 70(6):1139-49. PubMed ID: 6574284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.
    Koch N; Harris AW
    J Immunol; 1984 Jan; 132(1):12-5. PubMed ID: 6418793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
    Wilbur SM; Marelli O; Bonavida B
    Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.
    Stevenson FK; Elliott EV; Stevenson GT
    Immunology; 1977 Apr; 32(4):549-57. PubMed ID: 415966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen.
    Gordon J; Stevenson GT
    Immunology; 1981 Jan; 42(1):13-7. PubMed ID: 6970171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IA mutant functional antigen-presenting cell lines.
    Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
    J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression.
    Levine F; Pious D
    J Immunol; 1984 Feb; 132(2):959-62. PubMed ID: 6418815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma.
    Koch N; Wong GH; Schrader JW
    J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.